Trial Profile
Nalmefene Challenge to Modulate Neural Reactivity to Alcohol-related and Emotional Cues in Non-treatment Seeking Alcohol Dependent Participants
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 04 Aug 2022
Price :
$35
*
At a glance
- Drugs Nalmefene (Primary)
- Indications Alcoholism
- Focus Pharmacodynamics
- Acronyms NALCUE
- 01 Aug 2022 Results published in the Psychopharmacology
- 28 Jun 2017 Status changed from recruiting to discontinued.
- 07 Jan 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Apr 2016, as reported by ClinicalTrials.gov.